PL2018441T3 - LABELED MICROORGANISMS AND LABELING METHODS - Google Patents

LABELED MICROORGANISMS AND LABELING METHODS

Info

Publication number
PL2018441T3
PL2018441T3 PL07777180T PL07777180T PL2018441T3 PL 2018441 T3 PL2018441 T3 PL 2018441T3 PL 07777180 T PL07777180 T PL 07777180T PL 07777180 T PL07777180 T PL 07777180T PL 2018441 T3 PL2018441 T3 PL 2018441T3
Authority
PL
Poland
Prior art keywords
bacteria
microorganisms
members
tagged
preferred embodiments
Prior art date
Application number
PL07777180T
Other languages
Polish (pl)
Inventor
Rodolphe Barrangou
Christophe Fremaux
Philippe Horvath
Dennis Romero
Original Assignee
Dupont Nutrition Biosci Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38669481&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2018441(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dupont Nutrition Biosci Aps filed Critical Dupont Nutrition Biosci Aps
Publication of PL2018441T3 publication Critical patent/PL2018441T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention provides methods for tagging and/or identifying microorganisms. In some preferred embodiments, the microorganisms are bacteria. In some particularly preferred embodiments, the bacteria are members of the genus Streptococcus, while in other embodiments, the bacteria are members of other genera. The present invention also provides microorganisms tagged using the methods set forth herein. In some preferred embodiments, the tagged microorganisms are bacteria. In some particularly preferred embodiments, the tagged bacteria are members of the genus Streptococcus, while in other embodiments, the tagged bacteria are members of other genera.
PL07777180T 2006-05-19 2007-05-18 LABELED MICROORGANISMS AND LABELING METHODS PL2018441T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74768206P 2006-05-19 2006-05-19
US90472107P 2007-03-02 2007-03-02
EP07777180.6A EP2018441B2 (en) 2006-05-19 2007-05-18 Tagged microorganisms and methods of tagging
PCT/US2007/012039 WO2007136815A2 (en) 2006-05-19 2007-05-18 Tagged microorganisms and methods of tagging

Publications (1)

Publication Number Publication Date
PL2018441T3 true PL2018441T3 (en) 2012-03-30

Family

ID=38669481

Family Applications (2)

Application Number Title Priority Date Filing Date
PL07777180T PL2018441T3 (en) 2006-05-19 2007-05-18 LABELED MICROORGANISMS AND LABELING METHODS
PL11161778T PL2426220T3 (en) 2006-05-19 2007-05-18 Tagged microorganisms and methods of tagging

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL11161778T PL2426220T3 (en) 2006-05-19 2007-05-18 Tagged microorganisms and methods of tagging

Country Status (7)

Country Link
US (2) US9816140B2 (en)
EP (2) EP2426220B1 (en)
AT (1) ATE530669T1 (en)
DK (2) DK2426220T3 (en)
ES (2) ES2590925T3 (en)
PL (2) PL2018441T3 (en)
WO (1) WO2007136815A2 (en)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101688241B (en) * 2007-03-02 2015-01-21 杜邦营养生物科学有限公司 Cultures with improved phage resistance
FR2925918A1 (en) * 2007-12-28 2009-07-03 Pasteur Institut Typing or subtyping Salmonella bacteria comprises determining the variable sequence composition of a nucleic acid fragment amplified from the CRISPR1 and/or CRISPR2 locus
WO2010011961A2 (en) * 2008-07-25 2010-01-28 University Of Georgia Research Foundation, Inc. Prokaryotic rnai-like system and methods of use
US9404098B2 (en) * 2008-11-06 2016-08-02 University Of Georgia Research Foundation, Inc. Method for cleaving a target RNA using a Cas6 polypeptide
US10662227B2 (en) 2008-11-07 2020-05-26 Dupont Nutrition Biosciences Aps Bifidobacteria CRISPR sequences
WO2010066907A1 (en) * 2008-12-12 2010-06-17 Danisco A/S Genetic cluster of strains of streptococcus thermophilus having unique rheological properties for dairy fermentation
WO2010075424A2 (en) * 2008-12-22 2010-07-01 The Regents Of University Of California Compositions and methods for downregulating prokaryotic genes
DK2228436T3 (en) 2009-03-06 2016-04-11 Dupont Nutrition Biosci Aps The centrifugation and filtration methods for concentrating micro-organisms
US20110269119A1 (en) 2009-10-30 2011-11-03 Synthetic Genomics, Inc. Encoding text into nucleic acid sequences
MX2012013037A (en) 2010-05-10 2013-07-29 Univ California Endoribonuclease compositions and methods of use thereof.
CN103261213A (en) 2010-10-20 2013-08-21 杜邦营养生物科学有限公司 Lactococcus crispr-as sequences
US10323236B2 (en) 2011-07-22 2019-06-18 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
GB201122458D0 (en) 2011-12-30 2012-02-08 Univ Wageningen Modified cascade ribonucleoproteins and uses thereof
AU2013266968B2 (en) 2012-05-25 2017-06-29 Emmanuelle CHARPENTIER Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
PL3360964T3 (en) 2012-12-06 2020-03-31 Sigma-Aldrich Co. Llc Crispr-based genome modification and regulation
RU2662932C2 (en) 2013-03-14 2018-07-31 Карибо Биосайенсиз, Инк. Compositions and methods with use of nucleic acids targeted at nucleic acids
US10760064B2 (en) 2013-03-15 2020-09-01 The General Hospital Corporation RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
CN112301024A (en) 2013-03-15 2021-02-02 通用医疗公司 Improving the specificity of RNA-guided genome editing using RNA-guided FokI nuclease (RFN)
WO2014204578A1 (en) 2013-06-21 2014-12-24 The General Hospital Corporation Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing
US9234213B2 (en) 2013-03-15 2016-01-12 System Biosciences, Llc Compositions and methods directed to CRISPR/Cas genomic engineering systems
US9902973B2 (en) 2013-04-11 2018-02-27 Caribou Biosciences, Inc. Methods of modifying a target nucleic acid with an argonaute
EP2826379A1 (en) * 2013-07-17 2015-01-21 Dupont Nutrition Biosciences ApS Streptococcus thermophilus strains
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
CN106459995B (en) 2013-11-07 2020-02-21 爱迪塔斯医药有限公司 CRISPR-related methods and compositions using dominant gRNAs
US20150165054A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting caspase-9 point mutations
US10077453B2 (en) 2014-07-30 2018-09-18 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
CN107208070B (en) 2014-11-26 2021-09-07 技术创新动力基金（以色列）有限合伙公司 Targeted elimination of bacterial genes
CN116059378A (en) 2014-12-10 2023-05-05 明尼苏达大学董事会 Genetically modified cells, tissues and organs for the treatment of disease
WO2016205276A1 (en) * 2015-06-15 2016-12-22 North Carolina State University Methods and compositions for efficient delivery of nucleic acids and rna-based antimicrobials
GB2592821B (en) 2015-07-31 2022-01-12 Univ Minnesota Modified cells and methods of therapy
US9512446B1 (en) 2015-08-28 2016-12-06 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
US9926546B2 (en) 2015-08-28 2018-03-27 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
IL310721B2 (en) 2015-10-23 2025-11-01 Harvard College Nucleobase editors and their uses
CN105505976A (en) * 2015-12-25 2016-04-20 安徽大学 Construction method of penicillin-producing recombined strain of streptomyces virginiae IBL14
MX2018008345A (en) 2016-01-11 2018-12-06 Univ Leland Stanford Junior Chimeric proteins and methods of immunotherapy.
IL260532B2 (en) 2016-01-11 2023-12-01 Univ Leland Stanford Junior Systems containing chaperone proteins and their uses for controlling gene expression
CN110214183A (en) 2016-08-03 2019-09-06 哈佛大学的校长及成员们 Adenosine nucleobase editing machine and application thereof
WO2018031683A1 (en) 2016-08-09 2018-02-15 President And Fellows Of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
KR102622411B1 (en) 2016-10-14 2024-01-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 AAV delivery of nucleobase editor
CN110520530A (en) 2016-10-18 2019-11-29 明尼苏达大学董事会 Tumor infiltrating lymphocyte and treatment method
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
US12390514B2 (en) 2017-03-09 2025-08-19 President And Fellows Of Harvard College Cancer vaccine
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
US11542496B2 (en) 2017-03-10 2023-01-03 President And Fellows Of Harvard College Cytosine to guanine base editor
KR20240116572A (en) 2017-03-23 2024-07-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Nucleobase editors comprising nucleic acid programmable dna binding proteins
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
EP3645021A4 (en) 2017-06-30 2021-04-21 Intima Bioscience, Inc. ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY
CN111801345A (en) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 Methods and compositions for evolutionary base editors using phage-assisted sequential evolution (PACE)
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
KR20250107288A (en) 2017-10-16 2025-07-11 더 브로드 인스티튜트, 인코퍼레이티드 Uses of adenosine base editors
US12406749B2 (en) 2017-12-15 2025-09-02 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
US12522807B2 (en) 2018-07-09 2026-01-13 The Broad Institute, Inc. RNA programmable epigenetic RNA modifiers and uses thereof
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
WO2020191233A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
US12473543B2 (en) 2019-04-17 2025-11-18 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
IL297761A (en) 2020-05-08 2022-12-01 Broad Inst Inc Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
WO2023006885A1 (en) 2021-07-29 2023-02-02 Dupont Nutrition Biosciences Aps Compositions and methods for producing fermented plant-based compositions having cream flavor
US20240324620A1 (en) 2021-07-29 2024-10-03 Dupont Nutrition Biosciences Aps Compositions and methods for producing fermented dairy compositions having cream flavor
WO2023082047A1 (en) 2021-11-09 2023-05-19 Dupont Nutrition Biosciences Aps Compositions and methods for producing fermented dairy prod-ucts for storage at ambient temperature

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2225783A (en) 1939-04-07 1940-12-24 Lloyd B Jensen Sausage treatment
US3024116A (en) 1959-02-24 1962-03-06 Libby Mcneill And Libby Food processing
US3403032A (en) * 1967-10-04 1968-09-24 Agriculture Usa Pure culture fermentation process for pickled cucumbers
US3897307A (en) 1974-10-23 1975-07-29 Hansens Lab Inc Stabilized dry cultures of lactic acid-producing bacteria
US3932674A (en) * 1974-11-29 1976-01-13 The United States Of America Controlled bulk vegetable fermentation
US4140800A (en) * 1977-06-13 1979-02-20 Leo Kline Freeze-dried natural sour dough starter
US4205132A (en) * 1978-07-17 1980-05-27 Microlife Technics, Inc. Lyophilization of bacteria
US4423079A (en) 1980-07-14 1983-12-27 Leo Kline Growth promoting compositions for Lactobacillus sanfrancisco and method of preparation
US4621058A (en) 1983-04-11 1986-11-04 Mid-America Dairymen, Inc. Method of preparing cheese starter media
DE69132332T2 (en) * 1990-04-06 2000-11-30 Genelabs Technologies, Inc. HEPATITIS C-VIRUS-EPITOPE
NZ239638A (en) 1990-09-05 1993-12-23 Univ North Carolina State Bacteriophage resistant recombinant bacteria and their use in
AU3929793A (en) 1992-03-31 1993-11-08 Albert Einstein College Of Medicine Of Yeshiva University Prokaryotes including DNA encoding bacteriophage immunity
US5888725A (en) * 1992-09-22 1999-03-30 The Secretary Of State For The Minister Of Agriculture Fisheries And Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Method for identifying target bacteria
ATE169456T1 (en) 1996-12-23 1998-08-15 Sitia Yomo Spa LYOPHILIZED FOOD COMPOSITION CONTAINING LIVE BAKERIA
WO2003008631A2 (en) * 2001-07-20 2003-01-30 Health Protection Agency Tagging of microorganisms
US7919277B2 (en) * 2004-04-28 2011-04-05 Danisco A/S Detection and typing of bacterial strains
DK2341149T3 (en) 2005-08-26 2017-02-27 Dupont Nutrition Biosci Aps Use of CRISPR-associated genes (Cas)
WO2007144770A2 (en) 2006-06-16 2007-12-21 Danisco A/S Bacterium
CN103261213A (en) 2010-10-20 2013-08-21 杜邦营养生物科学有限公司 Lactococcus crispr-as sequences

Also Published As

Publication number Publication date
US20100104690A1 (en) 2010-04-29
DK2018441T4 (en) 2025-09-22
PL2426220T3 (en) 2017-01-31
ES2373586T3 (en) 2012-02-06
US9399801B2 (en) 2016-07-26
EP2426220B1 (en) 2016-06-22
US9816140B2 (en) 2017-11-14
DK2426220T3 (en) 2016-09-26
ATE530669T1 (en) 2011-11-15
EP2018441B2 (en) 2025-07-02
EP2018441B1 (en) 2011-10-26
WO2007136815A3 (en) 2008-01-31
ES2590925T3 (en) 2016-11-24
DK2018441T3 (en) 2012-01-02
US20080124725A1 (en) 2008-05-29
WO2007136815A2 (en) 2007-11-29
EP2018441A2 (en) 2009-01-28
EP2426220A1 (en) 2012-03-07

Similar Documents

Publication Publication Date Title
PL2018441T3 (en) LABELED MICROORGANISMS AND LABELING METHODS
DE602006015665D1 (en) PROBIOTIC ENTEROKOKEN FOR AN IMPROVED IMMUNITY
CY1116261T1 (en) ANTIBODIES AND IMMUNITIES AND THEIR USES
BRPI0600777A (en) method and system for the creation, storage, management and consumption of crop-specific data
ATE424159T1 (en) CATHETER
BRPI1011934A8 (en) COMPOSITION
BRPI0417823A (en) methods for using probiotic bifidobacteria for pets
GB2436983A (en) Information access with usage-driven metadata feedback
DK2094107T3 (en) Mycotoxin-reducing composition
CL2007003622A1 (en) Human anti-cd19 monoclonal antibody; composition comprising it; and tumor cell growth inhibition method.
NO20083397L (en) Anti-EphB4 antibodies and methods for their use
EP2333116A3 (en) Markers of renal transplant rejection and renal damage
DE602006015793D1 (en) PROTEOLIPIDE MEMBRANE AND LIPID MEMBRANE BIOSENSOR
BRPI0417825A (en) methods for using probiotic lactobacilli for pets
WO2010053606A3 (en) Small-molecule inhibitors of protein synthesis inactivating toxins
DE602008006254D1 (en) DOUBLE-OLIGONUCLEOTIDE NUCLEIC DETECTION METHOD
EP1788093A4 (en) BACTERIUM DETECTION INSTRUMENT, BACTERIUM DETECTION METHOD, AND BACTERIUM DETECTION KIT
WO2007010379A3 (en) Calorimetric assessment of microorganisms and use thereof
ATE452149T1 (en) MODIFIED POLYOLEFIN WAXES
DK1476029T3 (en) Bacterial autolysate
NO20064715L (en) Detection, isolation and use of renalase (monoamine oxidase C)
ATE460487T1 (en) SCREENING TEST FOR RIBOSOMAL ANTIBIOTICS
BRPI1014141B1 (en) culture method and medium for increased mycobacterial detection
BRPI0817090A2 (en) CULTURE METHOD AND A BACTERIAL SPECIES OF THE ANAPLASMATACEAE FAMILY, AND, COMPOSITION.
AR021469A1 (en) METHOD TO VISUALLY DEMONSTRATE THE EFFECTIVENESS OF AN ANTIBACTERIAL ADHESION COMPOSITION.